Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Prothrombin Complex for Hemophilia B Bleeding (Phase III, China)
CTR20181832Phase 3Completed
- Sponsor
- Tonglu Biopharmaceutical
- Start
- Oct 2018
- Modality
- Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of balfaxar in hemophilia B (HB), sponsored by Tonglu Biopharmaceutical. Started Oct 2018; status: completed.
02
Drugs
balfaxar
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on CTR20181832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181832.